학술논문

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
Document Type
Article
Source
In Lancet Oncology November 2013 14(12):1216-1225
Subject
Primary Research
Articles
Language
ISSN
1470-2045